Literature DB >> 7687133

Intraventricular galanin impairs delayed nonmatching-to-sample performance in rats.

J K Robinson1, J N Crawley.   

Abstract

Galanin is a neuroactive peptide that coexists with acetylcholine in the basal forebrain region. Galanin inhibits cholinergic functions in vitro and in vivo and has been shown to impair performance in some memory tasks. The present study compared the effects of galanin with the effects of scopolamine (a muscarinic antagonist) and ketamine and MK-801 (both NMDA receptor antagonists) on performance of an operant, spatial, delayed nonmatching-to-sample task in rats. Choice accuracy was impaired in a dose-dependent but delay-independent manner by galanin, scopolamine, and MK-801 but was not systematically influenced by ketamine. Measures of session duration, trials completed, discrimination accuracy, preservation, within-trial error distribution, and operant lever pressing were also analyzed. These results support observations that galanin disrupts performance in memory tasks requiring delayed responding but that the disruption is not specific to mnemonic capabilities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687133     DOI: 10.1037//0735-7044.107.3.458

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  11 in total

1.  Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease.

Authors:  R A Steiner; J G Hohmann; A Holmes; C C Wrenn; G Cadd; A Juréus; D K Clifton; M Luo; M Gutshall; S Y Ma; E J Mufson; J N Crawley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

Review 2.  Precision in mouse behavior genetics.

Authors:  D Pfaff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

3.  CSF galanin and cognition after shunt surgery in normal pressure hydrocephalus.

Authors:  M Mataró; M A Poca; M Del Mar Matarín; R Catalan; J Sahuquillo; R Galard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

4.  Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze.

Authors:  Kathleen R Bailey; Maria N Pavlova; Alex D Rohde; John G Hohmann; Jacqueline N Crawley
Journal:  Pharmacol Biochem Behav       Date:  2007-01-25       Impact factor: 3.533

Review 5.  Galanin: a potential role in mesolimbic dopamine-mediated instrumental behavior.

Authors:  John K Robinson; Ariel Brewer
Journal:  Neurosci Biobehav Rev       Date:  2008-06-03       Impact factor: 8.989

Review 6.  Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.

Authors:  M P McDonald; J N Crawley
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

7.  Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice.

Authors:  Jefferson W Kinney; Grzegorz Starosta; Andrew Holmes; Craige C Wrenn; Rebecca J Yang; Ashley P Harris; Katharine C Long; Jacqueline N Crawley
Journal:  Learn Mem       Date:  2002 Jul-Aug       Impact factor: 2.460

Review 8.  Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease.

Authors:  J N Crawley
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

9.  Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions.

Authors:  M P McDonald; L B Willard; G L Wenk; J N Crawley
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

10.  Improvement by dynorphin A (1-13) of galanin-induced impairment of memory accompanied by blockade of reductions in acetylcholine release in rats.

Authors:  M Hiramatsu; H Mori; H Murasawa; T Kameyama
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.